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ABSTRACT 
Psychosis, the inability to separate subjectivity and reality, can be either functional or organic. 
Organic psychoses are attributed to physical brain conditions, excluded by imaging. CT 
scanning requires evaluation regarding the detection of organic pathology in South Africa, 
with its high TB and HIV prevalence and resource limitations. 
Aim 
To determine the prevalence of structural brain abnormalities detected on CT in patients 
referred with a first-episode psychosis to a tertiary hospital in Johannesburg, South Africa. 
Materials & Methods 
One hundred and twelve CT brain scan reports of patients referred over a two-year period, 
after a first-episode psychosis, were retrospectively reviewed. Demographic data, HIV status, 
space-occupying lesions (SOL), ventricle size, abnormal calcifications and features of raised 
intra-cranial pressure were recorded. 
Results 
Eighty-eight of 112 patients were included in the sample [46 (52.3%) males; mean age 37 
years; range 16 – 67 years]. Eleven (20.8%) of the 53 patients evaluated for HIV tested 
positive. Of the 77 patients tested for syphilis, three (3.9%) tested positive. Sixteen (18.8%) 
patients had abnormalities on CT. Only two (2%) were deemed significant findings (a 
hypodensity in the left cerebral peduncle and features of mesiotemporal sclerosis). Three 
(3.4%) patients had enlarged ventricles. Seven (8%) patients had age-inappropriate 
involutional changes. Six patients (6.8%) had old calcified granulomata. No SOLs were 
detected. None had features of raised intra-cranial pressure. 
Conclusion 
The yield of abnormalities in CT brain scans in patients referred with a first-episode 
psychosis at our institution is high. However, only a small percentage of these are significant, 
can be attributed to the psychosis or affect management. 
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   CHAPTER 1:  
LITERATURE REVIEW 
 
This review will define and classify psychosis. It will give an outline of its demographics, 
etiology and investigation. We will critically evaluate the use of CT and MRI and discuss the 
CT brain imaging findings in psychotic patients. The current international guidelines on the 
diagnostic work-up of a first-episode psychosis (FEP) will be discussed as well as the yield of 
brain imaging in this group of patients. We will briefly discuss the role that HIV, syphilis and 
tuberculosis play in patients with FEP.  
1.1  PSYCHOSIS 
There are different definitions of psychosis documented in the literature.  
According to Kaplan and Sadock’s Synopsis of Psychiatry, the most common psychiatric use 
of the term psychosis refers to the “severe impairment of social and personal functioning 
characterised by social withdrawal and inability to perform the usual and occupational roles”. 
They further elaborate to define psychosis as “[the] inability to distinguish reality from 
fantasy; impaired reality testing, with the creation of a new reality (as opposed to neurosis: 
mental disorder in which reality testing is intact; behaviour may not violate gross social 
norms, but is relatively enduring or recurrent without treatment).”(1) 
Stedman’s Medical Dictionary, on the other hand, defines psychosis as,  
“A mental disorder causing gross distortion or disorganization of a person’s mental 
capacity, affecting response, and capacity to recognize reality, communicate, and 
relate to others to the degree of interfering with his capacity to cope with the ordinary 
demands of everyday life” (2).  
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1.1.1  Psychosis classification 
Psychosis is a symptom and not a diagnosis in itself. The psychoses are divided into two 
major groups depending on their origin: 1) those related to organic brain syndromes and 2) 
those that have some functional component and are not clearly organic by nature (3).   
1.1.2  Demographics 
In the United Kingdom (UK) most psychotic episodes (83.3%) occur in the 15-59 year age 
group followed by 16.5% in the age group older than 60 years. The least percentage (0.2%) 
occurs in those younger than 14 years of age (4). The majority of the patients in the UK were 
male (59%) (4). South African data of mentally ill inpatients scanned that presented either 
with (i) a first episode psychosis or (ii) psychosis and features of a delirium, focal physical or 
neurological signs, and/or abnormal special investigation results,correlate with these age and 
gender trends (5).  
1.1.3  Etiology 
Etiology differs by gender and age. In younger patients the cause is more commonly 
functional in nature whilst in the elderly organic causes are more prevalent (4, 5). 
Although there is renewed debate about the classification of the psychoses (6) functional 
psychoses include schizophrenia, bipolar mood disorder and mania, and form the majority of 
the psychoses (3). 
In the UK the incidence of organic pathology resulting in psychosis is estimated to be 
between five and ten percent (4). 
Organic psychoses can be attributed to physical medical conditions such as previous head 
trauma, encephalitis or a space-occupying brain lesion (for example, a tumour) (7).  
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A viral etiology for psychosis has been suggested. Psychotic symptoms may be caused by 
limbic encephalitis secondary to Epstein-Barr, cytomegalovirus, rubella, herpes simplex, 
measles and HIV viruses (8).  
In Alzheimer’s disease, psychosis is often a non-cognitive condition that accompanies 
dementia whereas in Parkinson’s disease, treatment with anti-parkinsonian drugs is the most 
frequent cause of psychotic symptoms (9).  
People with multiple sclerosis rarely develop psychotic symptoms (8).  
Psychosis in epilepsy does occur and is episodic rather than continuing with normal interictal 
periods (10). 
Organic psychoses are commonly of acute onset and where a space-occupying lesion is the 
cause associated, neurological manifestations are usually found. These might include cranial 
nerve paralyses, motor neuron impairment, sensory loss as well as speech and hearing 
difficulties (7).  
Unusual features such as an acute onset and delirium characterise organic psychoses and may 
lead the clinician to suspect an organic rather than a functional cause. Some of these patients 
presenting with psychosis may have obvious underlying psychiatric pathology, may have 
used psychosis-inducing agents or have a history of previous head trauma (7). 
For many of these patients, however, the cause of their psychosis will be unknown.  
1.2  FIRST-EPISODE PSYCHOSIS 
1.2.1  Definition 
Also known as an index-episode psychosis, it refers to the first time that an individual 
experiences a psychotic episode. It is sometimes difficult to determine the exact time of onset. 
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In practice this translates into an individual who presents to healthcare with psychosis and 
who has never previously presented to healthcare with psychosis (11). There is however no 
consensus operational definition for first episode psychosis (11).  
Studies revealed that early intervention (within three to five years) resulted in symptom 
improvement, lower relapse rates and promoted functional recovery (12). 
1.2.2  Diagnostic work-up for first-episode psychosis 
In addition to the routine physical, mental and neurological assessment, laboratory 
examinations are also conducted. These include: full blood count (FBC); renal function and 
electrolytes (U&E); liver functions (LFT); thyroid function tests (TFT); human 
immunodeficiency virus (HIV) status; and syphilis (TPHA and RPR). Furthermore 
cerebrospinal fluid (CSF) is evaluated biochemically and cytologically. Some cases may 
require an encephalogram (EEG) (13). 
1.3  BRAIN IMAGING 
Pathology may sometimes be missed when relying solely on the standard tests 
(misidentification syndrome) and thus CT and MRI may prove useful to diagnose organic 
pathology where it has been missed in the initial standard examinations. If all these tests yield 
no positive findings, it is assumed that the patient has functional psychosis (4). 
1.3.1  CT 
CT of the brain adds information on the structure of the brain, meninges and soft tissues of 
the head. Computed tomography uses ionising radiation to produce multiple axial two-
dimensional slices through the brain recorded by an array of detectors. The resultant images 
can be reconstructed into various planes of visualisation. It produces superior images of the 
bones and hard tissues compared to other imaging modalities. It may reveal pathologies such 
	   5	  
as space-occupying lesions, abnormal calcifications, involutional changes, cerebrospinal fluid 
space abnormalities and even meningitis. 
a) Findings on CT in patients with psychosis 
A number of studies have described CT changes noted in the brains of patients with first-
episode psychosis (5, 14-20)  (Table 1.1). Most of these changes are equivocal and non-
specific (20). 
These findings are likely to be influenced by factors such as age, gender, age of onset of 
psychosis, clinical symptoms, length and stage of illness and exposure to neuroleptics (21). 
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Table 1.1: Compilation and summary of studies evaluating the CT brain findings in 
patients with first-episode psychosis (constructed from references 3, 11-17).  
Study Normal 
n(%) 
AC0P0* 
n(%) 
AC+P0* 
n(%) 
AC+P+* 
n(%) 
Beresford (16) 
1986 
106 (68) 22 (14.1) 
6 cerebral atrophy 
2 cerebral and cerebellar atrophy 
2 ventricular enlargement 
2 superior cerebellar vermis atrophy 
1 bifrontal atrophy 
1 enlarged third ventricle 
1 old surgical lesion 
2 frontal lobe atrophy 
1 old craniotomy 
1 orbit mucocoele 
1 midfrontal hypodensity left 
1 parietal calcification left 
1 focal Sylvian fissure atrophy 
 
 
 
 
 
 
18 (11.5) 
2 ventricular outflow 
obstruction 
1 right frontal and left occipital 
infarcts 
1 patchy post fossa 
encephalomalacia 
1 small frontal haematomas 
1 subdural haematoma 
1 middle cerebral artery 
distribution encephalomalacia 
right 
1 putamen infarct right 
1 lacunar infarcts in putamen 
and internal capsule 
1 occipital infarct right 
2 putamen infarct left 
2 MCA territory atrophy left 
1 left frontal infarct 
1 frontal encephalomalacia 
1 left occipital infarct 
1 cerebral and cerebellar 
encephalomalacia 
10 (6.4) 
1 focal parietal atrophy 
1 encephalomalacia next 
to right lateral ventricle 
1 parietal and temporal 
lobe atrophy right 
1 right head of caudate 
infarct 
1 frontal and temporal 
hypodensity left 
1 temporal lobe stroke left 
1 temporal lobe atrophy 
1 metastatic lesion to left 
parietal lobe 
1 anterior parietal 
encephalomalacia left 
1 brain stem stroke 
 
Battaglia and 
Spector (15) 
1988 
42 (93.3) 
 
2 (4.4) 
2 atrophy (mild) 
1 (2.2) 
2 possible frontal white matter 
infarct 
1 (2.2) 
1 possible left caudate 
infarct 
Ananth (17) 
1993 
25 (73.5) 8 (23.5) 
1 mild central atrophy 
1 mild cerebral atrophy 
1 right frontal area of density 
1 generalised atrophy 
1 bifrontal atrophy 
1 prominent sulci 
1 asymmetrical Sylvian fissures 
1 mild atrophy left frontal lobe 
0 (0) 1 (2.9) 
1 post parietal and 
occipital attenuation 
 
Gerwitz et al. (14) 
1994 
93 (55.4) 71 (42.3) 
67 cortical atrophy (diffuse) 
2 arachnoid cysts 
1 ventricular enlargement 
1 venous angioma 
2 (1.2) 
1 right subcortical parieto-
temporal infarct 
1 ischaemic changes (diffuse) 
4 (2.4) 
1 moderately large right 
temporal arachnoid cyst 
1 parietal and subinsular 
infarcts (bilateral) 
1 parietal ischaemic 
changes (bilateral) 
1 colloid cyst obstructing 
foramen of Munro 
Bain (20) 
1998 
123 (96.9) 3 (2.4) 
1 subcortical right frontal calcification 
2 arachnoid cysts 
1 (0.8) 
1 possible pineal tumour 
0 (0) 
Agzarian (18) 
2006 
377 (95) 14 (3.5) 
5 cortical atrophy 
5 arachnoid cysts 
1 calcified choroid plexus in 4th 
ventricle 
3 non specific abnormalities disproved 
on MRI 
6 (1.5) 
3 small vessel ischaemic 
changes 
1 small right cerebellar 
cavernoma 
1 small calcified meningeoma 
1 colloid cyst without 
hydrocephalus 
0 (0) 
Hirano (19) 
2006 
88 (75.2) 18 (15.4) 
10 old infarcts 
3 age indeterminate infarcts 
2 lipoma 
1 hygroma 
1 chronic subdural 
1 post traumatic calcification 
11 (9.4) 
3 acute infarct 
3 intracranial haemorrhage 
1 subdural haematoma 
3 meningeoma 
1 pituitary adenoma 
 
0 (0)  
Jeenah (5)  
2007 
35 (63.6) 8 (14.4) 
7 global cerebral atrophy 
1 blow-out fracture of the orbit 
6 (11) 
6 old infarct +/- calcification 
6 (11) 
6 pituitary adenoma, TB 
granuloma, 
neurocysticercosis 
*(AC0P0) Abnormal finding on CT brain with unlikely relation to clinical picture or psychosis,  
(AC+P0) Abnormal finding on CT brain with a likely relation to clinical picture but not to the psychosis 
(AC+P+) Abnormal finding on CT brain with likely relation to clinical picture and psychosis 
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Ventriculomegaly 
Malla et al. found mild enlargement of the ventricles, the right temporal horn being larger 
than the left (21). Ventriculomegaly on CT was also documented by Hoffler et al. (22). Third 
ventricle prominence was noted in patients with schizophrenia but not in other psychotic 
disorders (23). Ichimiya and others, however, describe third ventricle enlargement as an 
inconsistent finding (21, 24). 
In refractory temporal lobe epilepsy (TLE), mesial temporal sclerosis is the most common 
pathologic entity found and is seen in as many as 60% to 80% of cases (25). Shukla et al. 
compared two groups of 62 with TLE and 90 with generalised epilepsy respectively and 
found that there was a statistically significant higher incidence of psychosis in the TLE group 
(26). Wyler describes atrophy and chronic herniation of the mesial temporal structures over 
the free edge of the tentorium in seventeen patients who had a CTB prior to temporal 
lobectomy (27). 
Cerebral atrophy 
Malla et al. found mild enlargement of cortical sulci in psychotic patients but noted that 
younger patients did not exhibit a significantly greater level of cerebral atrophy (21). Variance 
in the findings was mostly explained by age and not by variables such as clinical syndrome 
types, duration of illness or gender (21). Tsai and Tsuang studied 135 psychiatric patients’ 
brain scans. Of these nearly fifteen had atrophy (28). In a study by Evans on 100 consecutive 
psychiatric in- and outpatients, 66% had atrophy (29). Larson et al. found that 35% of a group 
of 123 patients with psychosis had atrophy (30). Some authors found the atrophy in the 
frontal and central brain regions to be progressive over a five-year period but Malla et al. 
found, if after controlling for the effect of age, the atrophy did not progress as a result of 
disease evolution (21, 31). They did, however, report progressive enlargement of the sylvian 
	   8	  
fissure due to chronic illness (21). In first-episode psychosis the left sylvian fissure appeared 
more prominent than the right (21). Other inconsistent findings reported include focal 
reduction in the size of the frontal lobes and involvement of the cerebellum (24). 
Infarcts 
In the elderly, organic pathology such as infarcts may result in psychotic behaviour. Anderson 
et al. reported on two cases of elderly females presenting with acute psychosis with occipital 
and subcortical infarcts respectively (32). They also noted that patients with a psychiatric 
history are more prone to psychosis following a stroke and that it is rarely reported owing to 
under recognition (32). 
Space-occupying lesions 
Asselman et al. noted that thirteen percent of 75 HIV positive patients with new neurological 
and psychiatric symptoms presented with a space-occupying lesion; one related to 
toxoplasmosis and nine of uncertain etiology (33). In a post-mortem study in 1978, Cole 
reported that in South African psychiatric patients the prevalence of space-occupying lesions 
was 15.5% (34). These lesions included: subdural haematomas, primary CNS neoplasms, a 
metastatic neoplasm, a hamartoma, tuberculomas, parasitic tapeworm cysts and an abscess 
(34). 
Brain tumours causing psychosis are rare and their prevalence on CT in the psychiatric 
population is about 1.2% (35). Three percent of the necropsy material studied by Cole had 
intracranial neoplasms (34). 
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Traumatic brain injury 
In a group of brain-injured troops from Finland, nearly 10% developed psychotic symptoms 
within 5 years (8). Only one patient in the series studied by Cole had evidence of head injury 
– a recent fall, resulting in a subdural haemorrhage (34). 
Arachnoid cysts 
Some anecdotal reports of patients presenting with first-episode psychosis and arachnoid cyst 
have been published (36, 37). The authors either did not ascribe the psychosis to the presence 
of the arachnoid cyst (36), or had difficulty in deciding whether or not the lesion was 
significant (37). 
Meningitis 
Cryptococcal meningitis is a known cause of psychosis (38). It was the cause of 
neuropsychiatric deterioration in 24% of 75 patients who were HIV positive and had been 
recently started on antiretrovirals (33). 
b) Advantages of CT 
Availability 
CT scanners are relatively widely available in the world (39). In South Africa it is the case in 
larger cities where secondary and tertiary hospitals are found. There is, however, a 
discrepancy between public and private distribution of these scanners. 
During 2005/2006 in the Western Cape Province of South Africa there were seven CT 
scanners available in 32 public hospitals and 24 CT scanners for 29 private hospitals. This 
means that a CT scanner was available for every 4.5 public hospitals and 1.2 for private 
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hospitals. During this period a total of 28 281 CT examinations were requested in the public 
sector while 36 519 CT examinations were ordered in the private sector (40). 
Cost 
The cost is less than that of MRI but remains relatively high. In 2009 a non-contrasted CT 
brain cost around R1 681.70; a contrasted CT of the brain cost in the order of R2 470.90 and a 
pre- and post-contrast scan cost the patient R3 005.50. An MRI cost between R4 736.90 and 
R7 724.60 depending on whether or not contrast was used (41). 
Quickness 
It is a relatively quick procedure, compared to MRI and takes between 15 to 30 minutes to 
acquire brain images depending on whether or not contrast was given. This results in fewer 
movement artifacts (39, 42). 
Additional findings 
Additional findings or pathologies in the surrounding tissues of the head might be 
serendipitously picked up in imaging the brain. 
Non-invasiveness 
Unlike a biopsy, a CT is a non-invasive method to exclude pathology. Moreover, unlike MRI, 
it is not contra-indicated in patients with pacemakers or metallic implants (39).  
c) Limitations and disadvantages of CT 
Patient factors 
For optimal visualisation, the patient must be able to lie still.  
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The average radiation dose to which people in the US are exposed has doubled over the past 
30 years (43). Ionising radiation is a well-known cause of deleterious effects in high doses 
and may even be carcinogenic. The life-time risk of cancer from a single brain CT is low (1: 
10 000 for those older than fifteen but younger than 20) but higher in the young (42). For this 
reason it is contra-indicated in pregnancy.  
CT has poorer soft-tissue contrast ability and fails to diagnose lesions with the same density 
as the surrounding tissue (39). In order to visualise these lesions and diagnose infection, 
iodinated contrast medium is often injected intravenously. It is not without any risk however. 
These compounds may cause permanent renal impairment and damage (39).  
Some patients may be allergic and can react fatally to the iodine in these contrast agents (44). 
Equipment factors 
There are a number of equipment related factors that can affect the quality of the scan and 
some that result in artifacts (45).  
There is 90% - 100% accuracy for mass lesions greater than 2.5 cm in diameter (46, 47).  
CT is also unable to diagnose some of the causes of psychosis such as dementia and epilepsy. 
In dementia, however, CT scanning is done to screen such patients for potentially treatable 
conditions such as hydrocephalus, meningeoma and subdural haematoma (46). 
The number of CT scans of the brain conducted annually in South Africa is unknown (48). 
In our setting we are overburdened by requests for CT of various parts of the body. The great 
demand for CT results in long waiting lists and sometimes an unfortunate delay in an urgent 
CT. Complicating this matter, the old and overused equipment requires regular servicing and 
sometimes replacement of a faulty component.  
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1.3.2  MRI  
Compared to CT, MRI is a relatively new imaging modality.  
a) Advantages 
MRI has exquisite grey-white matter resolution. Unlike CT, it is possible to image in various 
planes. The coronal views are especially valuable in evaluating the frontal and limbic regions. 
3-D reconstruction of brain structures is possible (49). MRI is useful in, among others, 
morphometric brain studies, evaluation of brain tissue and metabolic function as well as in 
examining the cerebral blood flow (49).  
No ionising radiation is used. MRI poses minimal risk to the patient (49). 
b) Disadvantages 
Compared to CT, MRI is quite expensive (41). Its availability is limited to larger medical 
centres and cities. It is estimated that there were 2 MRI scanners for 32 public hospitals 
compared to 16 MRI scanners available to the 29 private hospitals during 2005/2006 in the 
Western Cape Province of South Africa (40). 
Patients with claustrophobia find the scanning unbearable (42, 49).  
MRI is contra-indicated in patients with pacemakers, certain implants, metallic foreign bodies 
and aneurysm clips (49).  
1.3.3  Yield of brain imaging 
Several studies have been conducted on imaging to determine the incidence of organic 
pathology that could be the cause of psychosis (5, 14, 16-20). 
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In an exploratory study of 55 psychiatric patients by Jeenah and Moosa (see Table 1) at Chris 
Hani Baragwanath Hospital in South Africa, 20 (36.4%) patients had abnormal CT brain 
scans (5). The abnormalities detected included blow-out fracture of the orbit (1%), old 
infarcts (6%), global cerebral atrophy (7%) and mass lesions (6%). These masses included: 
pituitary adenoma, TB granuloma and neurocysticercosis. There was a significant correlation 
between abnormalities and advancing patient age. Fifteen of the abnormal scans were of 
patients with a first-episode psychosis (5). The authors recommended further study with a 
larger sample size to determine the necessity for scanning all first-episode psychotic patients 
(5).  
The systematic review by Albon et al. of 25 studies found that in most studies, structural 
neuro-imaging identified very little that would influence patient management that was not 
suspected, based on a medical history and/or physical examination and there were more 
incidental findings (35). They found that in these studies only around 0,5% of patients had 
findings on CT that would have affected clinical management (35). In a study by Strahl et al. 
reports of 237 consecutive patients who provided a history of first-episode psychosis revealed 
no focal brain lesion that could be responsible for the psychosis. Unrelated findings included 
small vessel ischaemic changes, arachnoid cysts, cerebral atrophy and normal variants in 
17.6% of patients (36). None of these findings led to a change in management (36). Ebdrup et 
al. reviewed eight papers, including a total of 625 CT and 214 MRI scans. On CT, the 
incidence of potentially causal brain abnormalities was 0.8% and on MRI 3.3% (50). The 
findings had limited clinical consequences, however, and thus they concluded that there is no 
support for performing routine CT scans of first-episode psychotic patients (50). Hirano et al. 
reported that the overall yield of CT brain scans in elderly unselected hospitalised patients is 
low (19). They, however, did not consider elderly psychotic patients. The same conclusions 
were made by, among others, Bain (20) and Agzarian (18). The tendency noted from these 
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studies is that most of the CT scans conducted for first-episode psychosis are normal. This is 
followed by findings of an abnormality without any impact on the clinical or psychiatric 
manifestations. Findings that were believed to influence either the clinical or psychiatric 
picture ranged between 0 and 11.5%. The highest number of abnormal imaging findings 
related to psychosis was observed in the study by Jeenah and Moosa (5). They did, however, 
have one of the smaller sample sizes (i.e. 55). The study with the greatest sample size (i.e. 
397) was conducted by Agzarian (18). These findings confirmed the hypothesis that the 
abnormal findings in patients with a first-episode psychosis is very low and that the majority 
of scans are normal (18). 
1.4  INTERNATIONAL PSYCHOSIS WORK-UP GUIDELINES 
Guidelines for the work-up of first-episode psychosis vary among countries. The Royal 
Australian and New Zealand College of Psychiatrists (RANZCP) advocates a neuro-imaging 
of the new onset psychotic patient, while Britain is more conservative in their approach and 
do not suggest an initial CT of the brain (4, 51). Although the RANZCP advocates neuro-
imaging in first-episode psychosis, they acknowledge that currently no evidence is available 
that routine imaging alters outcome or clinical management (4, 51). They furthermore 
acknowledge that CT has a low yield for screening psychotic patients. They highlight the fact 
that MRI has been reported to have significant yield detecting clinically important findings 
but that no yield is available for patients that underwent screening MRI for psychosis (51). 
The American group of Hollister suggested the following as sound, high yield indications for 
brain imaging in psychiatric patients: 1) history of previous head trauma, stroke, neurological 
disease, Alzheimer’s disease or multi-infarct dementia; 2) abnormal neurological signs or 
organic mental signs (e.g. cognitive decline or confusion); or 3) a first psychotic episode after 
the age of 50 years (52). They found brain scanning not to be rewarding in patients with a 
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history of alcohol or substance abuse, mental disorders lacking additional neuropsychiatric 
abnormalities, or for the evaluation of seizure disorders or abnormal EEG patterns (52). The 
study dates back to 1996, relying on old CT technology and no MRI at their disposal. 
Moreover, the sample consisted of only 68 patients and did not study first-episode psychotic 
patients per se. 
Tsai et al. recommended that those psychiatric patients who had normal mental state 
examination (MSE); neurological examination (NE); EEG and Bender Gestalt test (BIP), 
could safely be excluded from having organic pathology requiring imaging by CT. Those who 
had normal ME and NE but abnormal BIP or EEG could also be excluded if they were 40 
years or younger with no history of head injury (28). Once again the study evaluates general 
psychiatric patients and did not exclusively investigate patients with FEP. 
In a review article by Goodstein in 1986, broad inclusion criteria for CT scanning of the brain 
in general psychiatric patients are suggested: 1) when symptoms of a significantly disabling 
psychiatric disease do not fit the classical descriptions for the illness; 2) where there is a high 
index of suspicion of a space-occupying brain lesion due to specific evaluation findings; and 
3) If the CT findings, whether positive or normal will potentially influence management, 
rather than merely satisfy the clinician’s academic curiosity (47).  
Goodstein suggested numerous specific inclusion criteria for CT of the brain (Table 2.2). 
 
 
 
 
	   16	  
 
Table 1.2: Inclusion criteria for CT brain of patients with psychosis (Table 
constructed from reference 10).  
Clinical  
Atypical psychiatric presentation.  
Atypical pre-hospital course in an otherwise “classic” 
psychiatric diagnosis. 
Severe affective illness or psychosis with no family 
history of such a disease. 
Unusually rapid deterioration of the psychiatric illness. 
Late onset of psychosis. 
Abrupt onset of psychosis. 
Abrupt personality change. 
Adult onset seizures. 
Mental retardation 
Unexplained rage or aggression 
Major decline in intellectual function and memory 
Stupor 
Gross head trauma 
Immunosuppression 
Anticoagulation 
Pseudodementia 
Abnormal EEG 
Focal CNS findings suggesting intracranial pathology 
 
Treatment response 
 Refractory or atypical response to usually 
effective doses of psychiatric medication or 
electroconvulsive therapy. 
Unexplained delirium during or persisting 
after an ECT treatment. 
Symptoms 
True vertigo. 
Incontinence not due to infection or other 
easily identifiable causes. 
Ataxia not caused by intoxication or other 
identifiable causes. 
Fluctuating or persistent delirium not due to 
drugs, alcohol, medicines or pyrexia. 
Ear pain with a discharge not accounted for 
by local infection. 
Unusual symptomatic headaches. 
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1.5  INFECTION AND PSYCHOSIS 
Infectious diseases remain the leading cause of death in South Africa. The chief infective 
disease culprits are HIV and TB (53). Due to the high prevalence of these diseases, a closer 
look at their relation to psychosis and the imaging findings thereof is necessitated. 
1.5.1  HIV  
It has been demonstrated that HIV per se may be associated with psychosis (54-56). First-
episode psychosis in HIV positive patients occurred in 0.2%-15% of patients. Säll et al. 
reviewed the files of 38 South African black male, HIV positive mine workers and found the 
incidence of psychosis to be 29% (57). CT scans were only conducted in 24% of these 
patients and only in 4 were some kind of pathological finding found. Three patients, who had 
concurrent features of dementia, demonstrated cerebral atrophy, wide ventricles and sulci on 
CT. The fourth patient had a lesion in the pituitary fossa (57). In another South African 
prospective observational cohort study of 75 HIV positive patients, reported by Asselman et 
al., 12% presented with psychosis (33). In the majority (five patients) Efavirenz (an 
antiretroviral agent) was thought to be the cause (33) as it is known to cause psychotic side-
effects (58). The highest incidence of psychosis was reported among patients in later stages of 
HIV disease and with HIV associated dementia. In one study 15% of 46 patients with HIV 
associated dementia presented with psychosis (59). This suggests that psychosis is a direct 
effect of the HIV infection on the CNS. Various hypotheses have been constructed to explain 
the pathogenesis of first-episode psychosis in HIV positive patients: subcortical 
neurodegeneration due to HIV itself or in the presence of other viral infections; psychosis 
secondary to HIV encephalopathy; brain damage from another underlying opportunistic 
infection, or an underlying dementia (60). The following factors contributed to the 
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development of psychosis in HIV positive patients: untreated HIV infection, cognitive 
impairment, dementia and a history of psychiatric disease or substance abuse (58).  
 
 
1.5.2 Tuberculosis  
In the study by Asselman, 36% of the 75 HIV positive patients started on antiretrovirals had 
neurological deterioration secondary to TB. All patients diagnosed with tuberculoma had a 
negative serum immunoglobulin G (IgG) analysis for Toxoplasma species (33) and thus 
immunological studies were not an accurate assessment of CNS infection with tuberculosis. 
In a case report, Woodroof ascribed a patient’s psychotic symptoms to structural damage from 
an intracranial tuberculoma (62). There is, however, a paucity of data in the literature on the 
association between patients suffering from first-episode psychosis and cerebral tuberculosis.  
 
 
1.5.3  Syphilis  
CNS involvement with concurrent syphilis infection is a common cause for neuropsychiatric 
symptoms (57). However, in a group of South African mine workers reviewed by Säll et al., 
53% of the HIV positive patients were tested for syphilis and only two tested positive (57). 
The RPR test is used for screening and a confirmatory TPHA test is conducted (61). 
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CHAPTER 2:  
INTRODUCTION 
 
2.1  RATIONALE 
The general opinion of CT brain scans done on first-episode psychotic patients, in order “to 
rule out organic pathology”, is that it does not yield a great amount of information. This 
creates a preconceived notion that these scans, on the whole, will be normal and therefore 
may impact on the bias of the reader. New imaging techniques e.g. magnetic resonance 
imaging (MRI) may be more appropriate but are not cost effective in our resource limited 
setting. The use of CT, when the yield of significant pathology is low, is even less appropriate 
as it exposes patients to high doses of radiation. 
 
2.2 AIM 
The purpose of this research study is to determine the utility of CT brain scans in first episode 
psychosis patients (referred from a tertiary hospital psychiatry service in Johannesburg, South 
Africa) based on abnormal findings. 
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2.3  OBJECTIVES 
The objectives of this study are divided in to primary and secondary objectives.  
Primary objectives: 
To: 
2.3.1  determine the prevalence of abnormalities on CT brain scans; 
2.3.2  categorise the abnormalities as either: i) bearing no clinical significance, ii) 
with clinical significance, but unlikely to cause the patient’s psychosis or iii) 
with clinical significance, and possibly contributing to the patient’s psychosis. 
Secondary objectives: 
 To: 
2.3.3  determine the prevalence of human immunodeficiency virus (HIV) and 
syphilis in the study population; 
2.3.4  stratify the abnormalities according to age, gender and HIV status. 
 
2.4  SCOPE OF THE RESEARCH STUDY 
The study will only focus on patients referred as a first-episode psychosis from the psychiatric 
service at the Charlotte Maxeke Johannesburg Academic Hospital (CMJAH).  
The CMJAH is a tertiary hospital serving not only the immediate Johannesburg population 
but also patients from around the Gauteng Province. 
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CHAPTER 3:  
METHODOLOGY 
In this chapter we will explain the type of study and discuss the study material and methods 
used to gather and analyse the data. Inclusion and exclusion criteria will be mentioned and the 
descriptors of the dataset will be defined. 
 
3.1  STUDY DESIGN 
This is a retrospective descriptive review of reports and patient records in one South African 
tertiary referral centre (CMJA Hospital in Johannesburg). 
3.2  SAMPLE 
A consultant radiologist reviewed the CT brain scan reports of patients referred with a first-
episode psychosis. One hundred and twelve of these reports in conjunction with patient 
records and laboratory results review were dealt with.  
3.3  INCLUSION AND EXCLUSION CRITERIA 
The study included CT reports spanning a period of fourteen months (January 2009 to March 
2010) of patients referred after a first episode of psychosis at the Charlotte Maxeke 
Johannesburg Academic hospital (CMJAH) for the purposes of ruling out organic pathology. 
At the time of the original reading, the radiologists were blind to the clinical details with the 
exception of the history provided by the referring clinician on the request form. 
Only patients who had a true index psychotic episode were included. False referrals were 
excluded from the study. One hundred and twelve patients’ reports and folders were 
reviewed. Twenty-four patients had to be excluded owing to the fact that they did not present 
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with a true first-episode psychotic episode. A patient was regarded to have a first psychotic 
episode if folder or discharge summary review revealed no previous admission for psychosis 
was made, the patient received no antipsychotics in the past and collateral history revealed no 
prior psychotic episode. 
3.4  METHOD 
All the scans reviewed in this study were conducted in a standardised manner, as is routine 
practice in the department. Non-contrast, computed tomograms were performed on one of two 
CT machines in the department and reported by various radiology consultants and registrars. 
3.5  DATA ANALYSIS AND STATISTICAL METHODS 
Data was recorded in an Excel spreadsheet and statistical analysis was performed using the 
Statistica 8.0 package. Data was summarised as mean (SAD) or median (range) when 
distribution was normal or not normal respectively and variables were measured in a 
continuous scale. Categorical data is shown as frequencies, percentages and with a 95% 
Confidence Interval. 
For comparison between categorical variables a Chi-square or Fisher Exact Test when 
adequate was used. Significance was set at 0.05. 
The following data was extracted: 
a) Demographics 
The patients’ gender and age were recorded.  
b)  Index episode 
From the record or discharge summary it was ascertained whether the current psychotic 
episode was indeed the index or first episode 
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c)  HIV status 
The HIV status was recorded either as a) positive, b) negative or c) not tested. 
If the patient tested positive for HIV, the CD4 count (cells/µL) was also evaluated. 
d) Syphilis status 
Both the RPR and TPHA test results were documented and recorded either as a) positive, b) 
negative or c) not tested. 
e) CT brain findings 
 i) Features of raised intra-cranial pressure 
If the surface sulci, ventricles and/or basal cisterns were attenuated and/or the foramen 
magnum was crowded, the patient was deemed to have raised intra-cranial pressure. It was 
recorded as either a) present or b) absent. 
 ii) Ventricular size and shape 
Ventricular size was recorded as either a) normal; b) attenuated; c) enlarged but not 
hydrocephalic; d) hydrocephalic; e) asymmetric or f) in keeping with normal pressure 
hydrocephalus. If the ventricles were asymmetric, the location of the asymmetry was noted if 
described (e.g. posterior horn of the left lateral ventricle). 
 iii) Involutional changes 
Involutional changes were recorded as either absent or present. If present, they were classified 
as either being age appropriate or age inappropriate. 
The principles of Le May (63) were applied retrospectively to the report findings recorded 
regarding the following features: From the fourth decade there is gradual widening of
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third ventricle, sylvian and interhemispheric fissures, superficial sulci and basal cisterns (63). 
After the sixth decade, enlargement of the lateral ventricles is the most striking feature (63). 
Regressional changes are a normal aging process but highly variable (63). 
Involution occurring before the age of 50 years was regarded as being age inappropriate. 
Thereafter the changes were deemed to be age appropriate depending on their degree. The 
consultant radiologist reviewing the scan subjectively assessed the degree of involution. 
iv) Abnormal calcification 
Calcifications that are not considered as forming part of the normal or normal ageing brain 
were recorded. These were further characterised as being either a) granulomata (TB or old 
Neurocysticercosis); b) post traumatic or c) uncharacterised. 
v) Space-occupying lesions 
A space-occupying lesion was considered present if it occupied space and impinged on 
adjacent structures. Abnormal calcifications did not form part of this category and were 
recorded separately. 
f) Change in management 
The study of Goulet (42) served as the basis for our modified classification of abnormal CT 
brains (Table 3.1).  
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Table 3.1: Original and modified classification of Goulet 
Original classification of Goulet (42) Modified classification of Goulet 
1.  Normal. 
2.  Abnormal, with no clinical impact: benign or non-
 specific findings with no implication on diagnosis, 
 management, or treatment. We included in this 
 category all findings such as atrophy, fissure 
 enlargement, benign cysts, and other similar 
 matters. 
3.  Abnormal, with implication on management or 
treatment, but an unlikely causal link to psychotic 
symptoms. This group included findings warranting 
neurological investigation or treatment, such as the 
unexpected finding of an arterio-venous 
malformation, but with a high unlikelihood that 
treatment would influence the course of the 
psychosis. 
4.  Abnormal, with implication on management or  
 treatment, and a possible causal link to psychotic 
 symptoms. This group included the neurological 
 syndromes mentioned by Weinberger, lesions in key 
 cerebral regions already mentioned (temporal lobes, 
 diencephalon, and basal ganglia), and demyelinating 
 diseases. 
1. Normal. 
2. Abnormal, benign or non-specific findings 
bearing no influence on the diagnosis, 
management or treatment. In this category, 
amongst others, the following is included: 
atrophy, fissure prominence, benign cysts and 
the like. (AC0P0) 
3. Abnormal, with ramifications for 
management or treatment, but an unlikely 
causal link to psychotic symptoms. This 
group included findings requiring further 
neurological investigation or treatment, but 
with a low likelihood that treatment would 
affect the course of the psychosis. (AC+P0) 
 
4. Abnormal, with implication on management 
or treatment and a possible causal link to 
psychotic symptoms. This group included 
lesions in key cerebral regions such as the 
temporal lobes, diencephalon and basal 
ganglia. (AC+P+) 
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           CHAPTER 4:  
RESULTS 
This chapter will present the results of the data collection according to index episode, 
demographics, HIV status, syphilis serology and CT brain findings.  
4.1  INDEX EPISODE 
Only 88 patients (78.6%) actually presented with an index episode while 24 (21.4%) had a 
history of previous psychotic episodes. 
4.2  DEMOGRAPHICS 
The total of 88 patients included in the sample is comprised 46 (52.3%) males and 42 (47.7%) 
females (Table 4.1). No statistically significant difference was found between the prevalence 
of abnormalities when correlated with gender (χ2 test p=0.8405) (Figure 4.1). 
Table 4.1: Summary of the demographic results of 88 patients 
Variable Total (n=88) Abnormal (n=16) Normal (n=72) 
Male 46 (52.3%) 8 (17.4%) 38 (82.6%) 
Gender 
Female 42 (47.7%) 8 (19%) 34 (81%) 
16-30 34 (38.6%) 3 (8.8%) 31 (91.2%) 
31-60 50 (56.8%) 12 (24%) 38 (76%) Age group (years) 
>60 4 (4.6%) 1 (25%) 3 (75%) 
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Figure 4.1: Gender distribution of findings 
 
 
The mean age of these patients was 37 years (SD ± 13) and ranged from 16 to 67 years. There 
was no statistically significant difference between the prevalence of abnormalities when 
correlated with age (Fisher’s Exact Test1 p = 0.1433) (Figure 4.2).  
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1 Fisher’s Exact Test was used, instead of the χ2 test, owing to the small sample numbers.	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Figure 4.2: Distribution of findings by age 
 
In order to evaluate the relationship between age group and abnormalities without the 
influence of HIV, we evaluated the HIV negative group. Once again no statistically 
significant difference between age groups where CT abnormalities were found (Fisher’s Exact 
Test p=0.3598). 
 
 
 
 
 
Age	  group	  (years)	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4.3  HIV STATUS 
Only 53 patients were submitted to HIV testing. 
Eleven (20.8%) patients tested HIV positive; 42 (79.2%) tested HIV negative.  
Of the eleven HIV positive patients, the mean CD4 count was 301 cells/µL (SD ± 230) and 
ranged between 41 cells/µL and 707 cells/µL. The median CD4 count was 231 cells/µL. The 
highest prevalence of HIV is in the age group 31 – 60. The relationship between the 
prevalence of abnormalities and HIV appears to be slightly higher in this group, but not 
statistically significant (Fisher’s Exact Test p = 0.6634) (Table 4.2). 
Table 4.2: The influence of HIV status on scans results 
 Scan result 
HIV status Normal Abnormal 
HIV + (n = 11) 8 3 
HIV – (n = 42) 37 5 
Only 53 patients were submitted to HIV testing.  
The table reflects the scan results of the tested patients only.           
 
4.4  SYPHILIS SEROLOGY 
Seventy-seven patients were tested for syphilis. The remaining 11 were not submitted to 
testing. 
Three patients (3.9%) tested RPR positive. Seventy-four (96.1%) tested negative. There was 
no statistically significant correlation between the RPR positive patients and abnormal CT 
brain scans (Fisher’s Exact Test p = 0.4496) 
Six patients (7.8%) had a positive TPHA reaction; 71 (92.2%) negative. 
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4.5  CT BRAIN FINDINGS 
4.5.1  Raised intracranial pressure 
None of the patients’ scans displayed features of raised intracranial pressure. 
4.5.2  Ventricular size and shape 
The ventricles were normal in 85 (96.6%) patients. Three (3.4%) patients had enlarged but not 
hydrocephalic ventricles.  
4.5.3  Involutional changes 
Most of the patients, 80 (90.9%), had no involutional changes reported. Age appropriate 
involutional changes were described in one (1.1%) patient while seven (8%) patients had age 
inappropriate involutional changes. In most (five) of the patients with involutional changes, 
the affected area was not specified. In two patients, focal parietal and in another one left 
hemi-atrophy were described. 
4.5.4  Abnormal calcifications 
Six patients (6.8%) had abnormal intracranial calcifications. Of these, two were regarded as 
old neurocysticercosis and four calcifications were not specified. 
The location of the old neurocysticerci calcifications was not specified. The non-specified 
calcifications were located in the left basal ganglia, the right frontal and temporal lobes as 
well as in the left frontal lobe. 
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4.5.5  Space-occupying lesions 
Only one (1.1%) patient demonstrated a space-occupying lesion. This was described as a 
hypodense lesion in the left cerebral peduncle and further imaging via MRI was 
recommended. 
4.5.6  Other findings 
Scalp nodules were noted on the scan of one patient and a working diagnosis of possible 
neurofibromatosis was made. A biopsy was suggested. No intracranial features of 
neurofibromatosis were documented. 
4.6  CHANGE IN MANAGEMENT 
The brain scans were normal in 72 (81.8%) cases. 
Abnormalities were described in 16 (18.2%) patients’ scans.  
These abnormalities and their clinical importance are listed in Table 4.3. 
Table 4.3: Stratification of the impact of scans results according to the modified Goulet 
classification 
 
Classification Number (%) Findings [number of patients] 
Normal 72 (82%)  
AC0P0  14 (16%)  Old neurocysticercosis [2] 
 Age inappropriate involution changes [7] 
 Enlarged ventricles [3] 
 Unspecified granulomata [4] 
AC+P0 1 (1%) Hypodensity in the left cerebral peduncle [1] 
AC+P+ 1 (1%) CT features of left mesiotemporal sclerosis [1] 
 
Some patients had more than one anomaly, which explains why the sum of the findings results in 
a total slightly greater than the total number of abnormalities. Percentages, however, express 
proportion of subjects, not a proportion of all abnormalities. 
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Fourteen (15.9%) of the 16 abnormalities were graded to be without any clinical impact and 
thought to have no implication on the diagnosis, management or treatment of the patient. 
These abnormalities were thought not to contribute to the patient’s psychosis. 
One (1.1%) patient had abnormalities that may have had possible implications on 
management and treatment but were not deemed to have a causal link to the patient’s 
psychosis. This abnormality was a hypodense lesion in the left cerebral peduncle.  
One (1.1%) patient had an abnormality (left mesiotemporal sclerosis suggestive of temporal 
lobe epilepsy) that most likely impacted on further management and was thought possibly to 
contribute to the patient’s psychotic state. 
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CHAPTER 5:  
DISCUSSION 
This chapter discusses the results of the research presented in the previous chapter. These are 
viewed in conjunction with the preceding literature review in order to provide answers to the 
stated aim and objectives. 
5.1  DEMOGRAPHICS 
The gender distribution was nearly equal and matched that of similar studies elsewhere (5, 
64). 
Age distribution also matched international samples. The youngest patient in our population 
was 16 years of age. Most of the abnormalities occurred in the groups younger than 60 years 
of age. 
5.2  INDEX EPISODE 
An important observation is that 21.4% of all the cases referred as a first-episode psychosis 
turned out to have had a prior psychotic episode.  
We postulate that reasons for this might include improper or incomplete history taking by the 
examining clinician, inappropriate imaging referral or deliberate falsifying of the history in 
order to obtain a CT brain that would otherwise be denied. A MEDLINE search however, did 
not reveal any existing literature on the falsification of history in order to obtain medical 
imaging. This referral practice might be a topic for future investigation. 
5.3  HIV STATUS 
Although only 11 patients tested HIV positive, 39.8% of the 88 patients were not subjected to 
HIV testing. The reasons for this might include refusal by the patient to be tested, a low 
clinical suspicion by the examining clinician or non-adherence to work-up protocols.  
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The mean CD4 count of the HIV positive patients was not particularly low (301 cells/µL). 
Whether or not the patients received antiretroviral medication was not investigated.  
It does not seem, at least from this data, that an HIV positive patient has a proclivity to the 
development of an acute first-episode psychosis as noted in a Nigerian study where HIV 
positive patients had significantly higher rates of affective-, anxiety and psychotic disorders 
compared to their healthy controls (64). The authors found that both the lack of social support 
as well as the stage of disease contributed to the psychiatric manifestations (64). 
5.4  SYPHILIS SEROLOGY 
There was discordance between the RPR and TPHA tests as seven patients tested positive on 
RPR but ten patients on TPHA. Discrepant syphilis results require further confirmatory tests. 
None such tests were recorded in the NHLS laboratory database. As the RPR test is the first 
screening test that would prompt further confirmatory testing, concordant positive RPR and 
TPHA tests were regarded as positive for syphilis. Three (3.4%) patients tested positive for 
both RPR and TPHA and were deemed to have syphilis. This is in agreement with the 
findings of Säll (57). 
Eleven patients (12.5%) were not submitted to syphilis testing. Once again the reasons for this 
might include: patient refusal, a low clinical index of suspicion by the examining clinician or 
non-adherence to departmental work-up protocols. 
5.5  CT BRAIN FINDINGS 
5.5.1  Raised intracranial pressure 
None of the patients displayed structural features of raised intracranial pressure. Frequently 
scans are requested to exclude features of raised intracranial pressure so that the clinician can 
perform a lumbar puncture without the risk of brain herniation. 
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5.5.2  Ventriculomegaly 
Although ventriculomegaly (65) and ventricular asymmetry (36) is a known pathologic 
feature of CT brain scans in patients with psychosis, in our population only 3.4% of the 
patients had abnormal ventricular configuration. Reasons for this low figure might include: 
subtle ventriculomegaly, which might be missed; an apparently insignificant finding that is 
disregarded or not mentioned in the report. General radiologists might not be aware of the 
significance of ventriculomegaly in this subset of patients. 
5.5.3  Involutional changes 
Our findings are similar to those of Malla et al. (21). Only nine percent of patients had 
involutional changes and it is per se not a predictor or marker for psychosis. 
The CT diagnosis of mesiotemporal sclerosis is doubtful, as computed tomography is an 
insensitive tool for the workup of medically refractory epilepsy. Surrounding bone and beam 
hardening artifact contributes to the poor visualisation of this area. Bronen and co-workers 
(66) concluded that CT is not useful in the diagnostic imaging evaluation of refractory 
epilepsy compared to MRI. In their study, the sensitivity of MRI was superior (95%) 
compared to that of CT (32%). The ability of MRI to locate mesial temporal sclerosis was 
uncontested when compared to CT (98% vs 2%). 
5.5.4  Abnormal calcifications 
Of the six patients with abnormal calcifications, two were deemed to be old neurocysticerci 
granulations whilst the other calcifications were not ascribed to any specific etiology. 
Tuberculosis is prevalent in South Africa and thus a possible cause; however, no active 
tuberculomas were recorded. The relationship between calcifications and psychosis is not 
established. 
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5.5.5  Space-occupying lesions 
The hypodense lesion in the left cerebral peduncle was the only non-calcific mass lesion 
noted in the brain. The precise nature of this lesion was not clear and further imaging via MRI 
was suggested. This lesion was regarded as clinically significant but the causality to the 
patient’s psychosis was not proven.  
 
5.6  IMPACT OF CT BRAIN SCANS 
CT has established itself as an invaluable and relatively affordable tool in the initial 
evaluation of intracranial pathology. It is not without shortcomings however. It is unable to 
match the superb soft tissue differentiation of MRI. In a setting where the prevalence of 
clinically significant pathology is low, the question should be asked whether this practice 
should continue unaltered. 
This research makes a contribution by validating findings from numerous previous studies 
(18-20) that found a low yield of clinically significant findings that might also be related to 
the patient’s psychosis. The majority of the abnormalities included ventricular prominence 
and involutional changes that would not necessarily affect the patient’s management. 
In this study the sample size is small, albeit nearly double the numbers of similar studies 
conducted in a nearby institution (5). It is a retrospective analysis of various consultant-
reviewed reports that begs the question about the consistency and standardised manner in 
which these scans were reported. 
This study at least supports the recommendations by Hollister for CT brain imaging (52). The 
following are regarded as sound indications for a CT of the brain in a patient with a first-
episode psychosis: history of previous head trauma, stroke, neurological disease, Alzheimer’s 
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disease or multi-infarct dementia; abnormal neurological signs or organic mental signs (e.g. 
cognitive decline or confusion); or a first psychotic episode after the age of 50 years. 
Furthermore, this study did not support the general idea that patients infected with HIV or 
syphilis have a higher prevalence of psychosis. 
5.7  LIMITATIONS OF THE STUDY 
Study design 
The significance of this study is hampered by its retrospective design. It could not have taken 
account for the multiple readers, different scanners used, inconsistent scan settings and scan 
protocols.  
 
System or practice limitations  
These include poor record keeping and insufficiently detailed reports as well as inconsistency 
in the grading of involution and ventricle size. 
 
Sample size 
All these factors contributed to the small sample size. Several hundred patients should be 
included owing to the relative infrequency of true-positive findings. 
 
Population 
The population only includes patients referred from one tertiary hospital’s psychiatric service. 
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CHAPTER 6:  
CONCLUSION 
The yield of abnormalities in CT brain scans in patients referred with a first-episode 
psychosis at our institution is high. However, only a small percentage of these are significant, 
can be attributed to the psychosis or affect management. 
Is further research needed after all the published evidence? The relevance of further study 
seems valid if future research consists of several hundred patients, are designed as 
prospective, multicentre and double blind evaluated studies. Attempts at classifying 
abnormalities should be made along the groups described by Goulet (42). 
If ventricle size is to be described, objective evaluation of ventriculomegaly must be made, as 
the descriptive approach is vague and non-specific. 
The clinical significance of findings should be evaluated in consultation with a psychiatrist, 
neurologist and/or neurosurgeon. 
A comparison should be made between the findings on CT and MRI. We believe that MRI 
might shed more light on the underlying pathology of first-episode psychosis than CT. 
The cost-effectiveness of imaging patients with FEP should be evaluated.  
An interesting observation made was that of the apparent falsification of the patient’s history 
in order to obtain a CT scan. This practice is not described in the literature and warrants 
further investigation.                         
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8.1 DATA COLLECTION SHEET 
NO PT ID AGE GENDER RPR HIV CD4 RICP SOL Ventricle size Involution Location Calc Calc Nature ABN GRADE
1 = M 1 =  + 1 =  + 0 = no 0 = no 1=normal 1=none 0 = N/A 0 = no 1=NCC 0=normal
2 = F 2 = - 2 = - 1 = yes 1 = yes 2=attenuated 2=AGE + 1=frontal 1 = yes 2=TB 1=A+C0P0
3 = N/T 3 = N/T 3=enlarged 3=AGE - 2=parietal 3=N/S 2=A+C+P0
4=HC 3=temporal 0=N/A 3=A+C+P+
5=Asymmetry 4=occipital
6=NP HC 5=general
6=N/S
7= L hemi-A
8= R hemi-A
1 1 22 1 2 2 0 0 1 1 0 0 0 0
2 2 17 2 2 2 0 0 1 1 0 0 0 0
3 3 22 1 2 3 0 0 1 1 0 0 0 0
4 5 40 2 3 2 0 0 1 1 0 0 0 0
5 6 22 1 2 3 0 0 1 1 0 0 0 0
6 7 43 2 2 1 510 0 0 1 1 0 0 0 0
7 8 41 2 2 3 0 0 1 1 0 0 0 0
8 9 24 1 2 2 0 0 1 1 0 0 0 0
9 10 48 2 2 2 0 0 1 1 0 0 0 0
10 11 32 2 2 2 0 0 1 1 0 1 1 1
11 12 33 1 2 1 115 0 1 1 1 0 0 0 2
12 13 20 1 3 3 0 0 1 1 0 0 0 0
13 15 51 2 1 2 0 0 1 1 0 0 0 0
14 18 41 1 2 3 0 0 1 3 2 0 0 1
15 19 23 2 2 2 0 0 1 1 0 0 0 0
16 21 36 2 3 3 0 0 1 1 0 0 0 0
17 22 26 2 3 2 0 0 1 1 0 0 0 0
18 23 40 2 2 2 0 0 1 1 0 0 0 0
19 24 42 1 2 2 0 0 1 1 0 0 0 0
20 25 25 1 3 3 0 0 1 1 0 0 0 0
21 26 22 2 2 2 0 0 1 1 0 0 0 0
22 27 27 2 2 2 0 0 1 1 0 0 0 0
23 28 33 1 3 3 0 0 1 1 0 0 0 0
24 29 46 1 2 2 0 0 1 1 0 0 0 0
25 30 45 1 2 3 0 0 1 1 0 0 0 0
26 31 46 1 2 2 0 0 1 1 0 0 0 0
27 32 53 1 2 2 0 0 1 1 0 0 0 0
28 33 49 2 1 2 0 0 1 1 0 1 3 1
29 34 46 2 3 3 0 0 3 1 0 0 0 3
30 35 49 1 3 3 0 0 1 1 0 0 0 0
31 36 23 1 2 2 0 0 1 1 0 0 0 0
32 37 21 2 2 1 231 0 0 1 1 0 0 0 0
33 38 47 2 2 3 0 0 1 1 0 0 0 0
34 40 38 2 2 1 179 0 0 1 3 6 1 3 1
35 41 49 1 2 3 0 0 3 1 0 0 0 1
36 42 16 1 2 3 0 0 1 1 0 0 0 0
37 43 22 2 2 2 0 0 1 1 0 0 0 0
38 44 50 1 2 3 0 0 1 3 7 0 0 1
39 45 42 2 2 2 0 0 1 1 0 0 0 0
40 46 45 1 2 3 0 0 1 1 0 0 0 0
41 47 31 2 2 1 179 0 0 1 1 0 0 0 0
42 48 18 2 2 2 0 0 1 1 0 0 0 0
43 49 19 1 2 2 0 0 1 1 0 0 0 0
44 50 42 2 2 2 0 0 1 1 0 0 0 0
45 51 39 2 2 3 0 0 3 1 0 0 0 1
46 52 32 1 3 3 0 0 1 1 0 0 0 0
47 53 30 2 2 2 0 0 1 1 0 0 0 0
48 54 47 1 2 3 0 0 1 1 0 0 0 0
49 55 47 1 2 3 0 0 1 1 0 0 0 0
50 56 42 2 2 2 0 0 1 1 0 1 3 1
51 57 60 2 2 2 0 0 1 1 0 0 0 0
52 59 25 1 2 3 0 0 1 1 0 1 1 1
53 61 42 1 2 3 0 0 1 1 0 0 0 0
54 62 31 1 2 3 0 0 1 1 0 0 0 0
55 63 23 1 2 3 0 0 1 1 0 0 0 0
56 64 45 2 2 1 230 0 0 1 1 0 0 0 0
57 65 53 2 2 2 0 0 1 1 0 0 0 0
58 66 21 1 2 2 0 0 1 1 0 0 0 0
59 68 47 2 2 1 41 0 0 1 1 0 0 0 0
60 69 40 1 2 3 0 0 1 1 0 0 0 0
61 70 62 1 2 3 0 0 1 1 0 0 0 0
62 71 28 2 3 3 0 0 1 1 0 0 0 0
63 72 45 2 2 3 0 0 1 1 0 0 0 0
64 73 50 1 2 2 0 0 1 1 0 0 0 0
65 74 65 2 2 2 0 0 1 1 0 0 0 0
66 75 64 1 2 2 0 0 1 1 0 0 0 0
67 76 31 1 2 3 0 0 1 1 0 0 0 0
68 77 20 1 2 2 0 0 1 1 0 0 0 0
69 78 41 1 2 3 0 0 1 1 0 0 0 0
70 80 48 1 2 3 0 0 1 1 0 0 0 0
71 81 21 1 2 3 0 0 1 3 6 0 0 1
72 82 22 1 2 1 621 0 0 1 1 0 0 0 0
73 83 20 1 2 2 0 0 1 1 0 0 0 0
74 84 33 2 2 1 109 0 0 1 3 6 1 3 1
75 85 26 2 2 2 0 0 1 1 0 0 0 0
76 88 33 1 2 1 707 0 0 1 1 0 0 0 0
77 89 47 2 1 2 0 0 1 1 0 0 0 0
78 92 25 2 3 3 0 0 1 1 0 0 0 0
79 93 24 2 2 1 264 0 0 1 1 0 0 0 0
80 94 67 2 2 3 0 0 1 2 6 0 0 1
81 95 40 1 2 3 0 0 1 1 0 0 0 0
82 97 22 2 2 2 0 0 1 1 0 0 0 0
83 100 27 1 2 2 0 0 1 3 2 0 0 1
84 101 50 1 2 2 0 0 1 1 0 0 0 0
85 103 53 1 2 2 0 0 1 3 6 0 0 1
86 104 23 2 2 2 0 0 1 1 0 0 0 0
87 109 25 2 2 2 0 0 1 1 0 0 0 0
88 111 25 1 2 2 0 0 1 1 0 0 0 0
N/T = not tested, HC = hydrocephalus, NP HC = normal pressure hydrocephalus, AGE + = age appropriate involution,
AGE - = age inappropriate involution, L hemi-A = L sided hemi-atrophy,  R hemi-A = R sided hemi-atrophy, NS = not specified,
N/A = not assessed, NCC = neurocysticercosis, TB = tuberculosis
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